CTRI/2022/09/045713尚未招募未知
An Open label Prospective, Interventional study of effect of fixed dose (0.5mg/kg) Intra-muscular Ketamine on patients having suicidal ideations attending tertiary care hospital.
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Having suicidal ideations (MADRS-SI score >3)
- •2. Who gave consent
排除标准
- •1. Present diagnosis or antecedents of clinically relevant cardiovascular disorders such as stroke, heart attack, etc.
- •2. Present or past diagnosis of glaucoma, intracranial hypertension.
- •3. Current diagnosis of schizophrenia as defined in the ICD-11.
- •4. Patients with any known hypersensitivity to ketamine.
- •5. patients who are hemodynamically unstable.
- •6. Delirious patients.
- •7. Pregnancy.
研究者
相似试验
尚未招募
2 期
Panchakarma procedures in the management of Rheumatoid arthritisCTRI/2021/09/036891Reetika Rana MD Student
进行中（未招募）
1 期
STRENSIQ® Immunogenicity StudyMedDRA version: 20.1Level: PTClassification code: 10049933Term: Hypophosphatasia Class: 100000004850HYPOPHOSPHATASIACTIS2022-502793-17-00Alexion Pharmaceuticals Inc.8
已完成
不适用
Interventional, open-label study investigating the absorption, metabolism and excretion (AME) of the research medication following a single oral dose of the 14C-labeled research medication to healthy memental disorder10039628NL-OMON40688undbeck6
招募中
2 期
The efficacy of anamorelin in patients with cachexia associated with chronic obstructive pulmonary diseasecachexia associated with chronic obstructive pulmonary diseasecachexiaD002100JPRN-jRCTs031230446Ikari Jun28
已完成
不适用
Interventional, open-label, exploratory study, investigating the safety, tolerability, pharmacokinetics, and efficacy of Lu AF28996 in patients with Parkinson*s disease10028037Parkinson's diseaseNL-OMON52830H. Lundbeck A/S12